TG Therapeutics Inc. sell The Goldman Sachs Group, Inc.
Start price
24.07.23
/
50%
€18.25
Target price
24.07.24
€14.44
Performance (%)
-1.86%
End price
25.07.24
€17.91
Summary
This prediction ended on 25.07.24 with a price of €17.91. With a performance of -1.86%, the SELL prediction by The_Goldman_Sachs_Gr was trending in the right direction. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| TG Therapeutics Inc. | 0.000% | 0.000% | 77.648% | 345.980% |
| iShares Core DAX® | -0.874% | 5.325% | 6.865% | 65.211% |
| iShares Nasdaq 100 | -0.381% | 1.979% | 25.696% | 90.325% |
| iShares Nikkei 225® | -1.676% | 1.952% | 41.443% | 80.623% |
| iShares S&P 500 | -0.655% | 2.069% | 21.405% | 70.737% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread TG Therapeutics Inc. diskutieren
TG Therapeutics, Inc. (NASDAQ: TGTX) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $10.00 to $16.00. They now have a "sell" rating on the stock.
Ratings data for TGTX provided by MarketBeat
In the thread Trading TG Therapeutics Inc.
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten